Barry Hart

Connecticut Innovations, Inc (CI) is venture capital firm founded in 1989. The firm is headquartered in Rocky Hill, Connecticut.

National Cancer Institute provides healthcare services. It specializes in different cancer treatment such as adrenocortical carcinoma, anal cancer, appendix cancer, skin cancer, breast cancer, cardiac tumors, endometrial cancer, and gallbladder cancer. The company was founded in March 1937 and is headquartered in Bethesda, MD.

Synthesis Capital is a venture capital firm founded in 2007. The firm is headquartered in Boston, Massachusetts.

Spear Therapeutics Ltd. develops cancer treatment drugs. The firm offers cytochrome P450 (CYP)-activated prodrugs. It designs prodrugs that are activated by enzymes that are found in cancer tissues. The company was founded by Steven A. Everett and Gerard Andrew Potter and is headquartered in Manchester, the United Kingdom.

Anadys Pharmaceuticals, Inc. develops and manufactures novel small molecule medicines. It engages in developing novel medicines in the areas of hepatitis C and oncology. The firm develops ANA598, a direct-acting antiviral for the treatment of hepatitis C. The company was founded by Stelios B. Papadopoulos and Kleanthis G. Xanthopoulos in 1992 and is headquartered in Little Falls, NJ.

Oridion Systems Ltd. develops medical devices for patient safety monitoring. It produces medical devices (hardware) and patient interfaces (consumables) based on its patented Microstream and Smart Capnography technologies for the enhancement of patient safety and clinical outcomes. It provides solutions for respiratory monitoring and airway management for patients which includes non-incubated patients, premature newborns and clinical environments which includes procedural sedation, pain management, critical care units, post-anesthesia care units, emergency medical services, transport and alternate care. It operates in Jerusalem, Israel, Needham, Massachusetts and the United States of America. The company was founded by Yacov Bubis in 1987 and is headquartered in Jerusalem, Israel.

Dana-Farber Cancer Institute, Inc. provides treatment to cancer patients and also researches new cancer diagnostics, treatments, and preventions. The firm's patients receive treatment through its cancer centers operated with Brigham and Women's Hospital, Children's Hospital Boston, Massachusetts General Hospital, and Beth Israel Deaconess Medical Center. The company was founded by Sidney Farber in 1947 and is headquartered in Boston, MA.

Bayer Healthcare LLC provides healthcare and pharmaceutical medicines. It also provides researching, developing, manufacturing and marketing services for the prevention, diagnosis and treatment of diseases. The company is headquartered in Whippany, NJ.

Cheminpharma LLC provides drug discovery services to biotechnology and pharmaceutical companies. The firm's products and services include protein control technology, Shield-1, Aqua Shield-1, Raksha-1, medicinal chemistry, custom synthesis, DMPK, In vitro Biology, analytical services and chemical matter evaluation. The company was founded by Uday R. Khire in March 2007 and is headquartered in Branford, CT.

White Cube Management LLC provides management services. The private company is based in Boston, MA.

Cellzome Ltd. engages in the research, development, and manufacture of pharmaceutical products. It provides kinase-targeted drugs to treat inflammatory diseases. The company was founded by Gitte Neubauer on December 22, 2003 and is headquartered in Middlesex, the United Kingdom.

Synbody Biotechnology, Inc. operates as a platform for the discovery and development of novel and attractive molecules. The company was founded by Paul L. Hallenbeck, Chris Diehnelt, Kevin D. Burroughs and Stephen Albert Johnston in 2010 and is headquartered in Chester Springs, PA.

New Haven Pharmaceuticals, Inc. develops new prescription drug products. It developes proprietary prescription pharmaceuticals that utilize currently marketed drugs or generally recognized as safe (GRAS) active pharmaceutical ingredients (APIs) for use in therapeutic applications. The company was founded by Harry H. Penner Jr. in 2008 and is headquartered in Branford, CT.

BioRez, Inc. engages in the design and development of resorbable polymer scaffold technology. The firm offers a device that is suited for tendon, ligament, and other soft tissue injuries. The company was founded by Cato T. Laurencin and Joseph W. Reilly in 2008 and is headquartered in New Haven, CT.

CuraGen Corp. develops protein, antibody and small molecule pharmaceutical products. The firm focuses on the development of CR011-vcMMAE, a Phase II clinical trial drug for the treatment of patients with metastatic melanoma and breast cancer. The company was founded in 1991 and is headquartered in Branford, CT.

P2 Science, Inc. operates as a specialty chemical biorefinery company. It offers cosmetics and personal care, flavors and fragrances, specialty materials, and bioactives. The company was founded by Neil A. Burns, Paul Anastas, and Patrick Foley in 2011 and is headquartered in Woodbridge, CT.

FMP Products, Inc. designs, manufactures and sells laboratory automation equipment to pharmaceutical companies. Its products include 3D digital video microscope with automated xyz stage and servo controlled micro manipulators. The company was founded by Thomas J. Friedlander And Walter Meltzer in 2005 and is headquartered in Danbury, CT.

SAMI Health, Inc. provides healthcare information technology services. It is developing information solutions for hospitals and other healthcare institutions. The company was founded by Richard R. Rakowski and Matt Walton in 2012 and is headquartered in Westport, CT.

EpiEP, Inc. develops heart-related medical devices. It has developed epicardial access system, EpiAccess, which engages a patent protected pressure-guided needle that is designed to alert physicians of needle tip location during epicardial access procedures. The firm specializes on instruments that facilitates an epicardial approach for patients who benefit from minimally invasive procedures on the surface of the heart. The company was founded by Pamela M. Bunes, Jason Tucker-Schwartz, Srijoy Mahapatra and George T. Gillies in December 2008 and is headquartered in New Haven, CT.

Tangen Biosciences, Inc. develops portable instruments and methods for use in molecular diagnostics. Its instrument provides rapid nucleic acid detection, with the specificity and sensitivity of polymerase chain reaction amplification. The company was founded by John R. Nobile and John Davidson in 2013 and is headquartered in Branford, CT.

Advent International LP (Advent) is an independent private equity firm founded in 1984 by Henry H. Haight. The firm is headquartered in Boston, Massachusetts.